Automated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease

(1) Background: COVID-19 continues to represent a worrying pandemic. Despite the high percentage of non-severe illness, a wide clinical variability is often reported in real-world practice. Accurate predictors of disease aggressiveness, however, are still lacking. The purpose of our study was to eva...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pierpaolo Palumbo, Maria Michela Palumbo, Federico Bruno, Giovanna Picchi, Antonio Iacopino, Chiara Acanfora, Ferruccio Sgalambro, Francesco Arrigoni, Arturo Ciccullo, Benedetta Cosimini, Alessandra Splendiani, Antonio Barile, Francesco Masedu, Alessandro Grimaldi, Ernesto Di Cesare, Carlo Masciocchi
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/da4fcf94af0943caa330f6233a15e65c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:da4fcf94af0943caa330f6233a15e65c
record_format dspace
spelling oai:doaj.org-article:da4fcf94af0943caa330f6233a15e65c2021-11-25T17:21:49ZAutomated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease10.3390/diagnostics111121252075-4418https://doaj.org/article/da4fcf94af0943caa330f6233a15e65c2021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2125https://doaj.org/toc/2075-4418(1) Background: COVID-19 continues to represent a worrying pandemic. Despite the high percentage of non-severe illness, a wide clinical variability is often reported in real-world practice. Accurate predictors of disease aggressiveness, however, are still lacking. The purpose of our study was to evaluate the impact of quantitative analysis of lung computed tomography (CT) on non-intensive care unit (ICU) COVID-19 patients’ prognostication; (2) Methods: Our historical prospective study included fifty-five COVID-19 patients consecutively submitted to unenhanced lung CT. Primary outcomes were recorded during hospitalization, including composite ICU admission for the need of mechanical ventilation and/or death occurrence. CT examinations were retrospectively evaluated to automatically calculate differently aerated lung tissues (i.e., overinflated, well-aerated, poorly aerated, and non-aerated tissue). Scores based on the percentage of lung weight and volume were also calculated; (3) Results: Patients who reported disease progression showed lower total lung volume. Inflammatory indices correlated with indices of respiratory failure and high-density areas. Moreover, non-aerated and poorly aerated lung tissue resulted significantly higher in patients with disease progression. Notably, non-aerated lung tissue was independently associated with disease progression (HR: 1.02; <i>p</i>-value: 0.046). When different predictive models including clinical, laboratoristic, and CT findings were analyzed, the best predictive validity was reached by the model that included non-aerated tissue (C-index: 0.97; <i>p</i>-value: 0.0001); (4) Conclusions: Quantitative lung CT offers wide advantages in COVID-19 disease stratification. Non-aerated lung tissue is more likely to occur with severe inflammation status, turning out to be a strong predictor for disease aggressiveness; therefore, it should be included in the predictive model of COVID-19 patients.Pierpaolo PalumboMaria Michela PalumboFederico BrunoGiovanna PicchiAntonio IacopinoChiara AcanforaFerruccio SgalambroFrancesco ArrigoniArturo CicculloBenedetta CosiminiAlessandra SplendianiAntonio BarileFrancesco MaseduAlessandro GrimaldiErnesto Di CesareCarlo MasciocchiMDPI AGarticleCOVID-19lung inflammationprognosistomography computed scannerslung volume measurementMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2125, p 2125 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
lung inflammation
prognosis
tomography computed scanners
lung volume measurement
Medicine (General)
R5-920
spellingShingle COVID-19
lung inflammation
prognosis
tomography computed scanners
lung volume measurement
Medicine (General)
R5-920
Pierpaolo Palumbo
Maria Michela Palumbo
Federico Bruno
Giovanna Picchi
Antonio Iacopino
Chiara Acanfora
Ferruccio Sgalambro
Francesco Arrigoni
Arturo Ciccullo
Benedetta Cosimini
Alessandra Splendiani
Antonio Barile
Francesco Masedu
Alessandro Grimaldi
Ernesto Di Cesare
Carlo Masciocchi
Automated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease
description (1) Background: COVID-19 continues to represent a worrying pandemic. Despite the high percentage of non-severe illness, a wide clinical variability is often reported in real-world practice. Accurate predictors of disease aggressiveness, however, are still lacking. The purpose of our study was to evaluate the impact of quantitative analysis of lung computed tomography (CT) on non-intensive care unit (ICU) COVID-19 patients’ prognostication; (2) Methods: Our historical prospective study included fifty-five COVID-19 patients consecutively submitted to unenhanced lung CT. Primary outcomes were recorded during hospitalization, including composite ICU admission for the need of mechanical ventilation and/or death occurrence. CT examinations were retrospectively evaluated to automatically calculate differently aerated lung tissues (i.e., overinflated, well-aerated, poorly aerated, and non-aerated tissue). Scores based on the percentage of lung weight and volume were also calculated; (3) Results: Patients who reported disease progression showed lower total lung volume. Inflammatory indices correlated with indices of respiratory failure and high-density areas. Moreover, non-aerated and poorly aerated lung tissue resulted significantly higher in patients with disease progression. Notably, non-aerated lung tissue was independently associated with disease progression (HR: 1.02; <i>p</i>-value: 0.046). When different predictive models including clinical, laboratoristic, and CT findings were analyzed, the best predictive validity was reached by the model that included non-aerated tissue (C-index: 0.97; <i>p</i>-value: 0.0001); (4) Conclusions: Quantitative lung CT offers wide advantages in COVID-19 disease stratification. Non-aerated lung tissue is more likely to occur with severe inflammation status, turning out to be a strong predictor for disease aggressiveness; therefore, it should be included in the predictive model of COVID-19 patients.
format article
author Pierpaolo Palumbo
Maria Michela Palumbo
Federico Bruno
Giovanna Picchi
Antonio Iacopino
Chiara Acanfora
Ferruccio Sgalambro
Francesco Arrigoni
Arturo Ciccullo
Benedetta Cosimini
Alessandra Splendiani
Antonio Barile
Francesco Masedu
Alessandro Grimaldi
Ernesto Di Cesare
Carlo Masciocchi
author_facet Pierpaolo Palumbo
Maria Michela Palumbo
Federico Bruno
Giovanna Picchi
Antonio Iacopino
Chiara Acanfora
Ferruccio Sgalambro
Francesco Arrigoni
Arturo Ciccullo
Benedetta Cosimini
Alessandra Splendiani
Antonio Barile
Francesco Masedu
Alessandro Grimaldi
Ernesto Di Cesare
Carlo Masciocchi
author_sort Pierpaolo Palumbo
title Automated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease
title_short Automated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease
title_full Automated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease
title_fullStr Automated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease
title_full_unstemmed Automated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease
title_sort automated quantitative lung ct improves prognostication in non-icu covid-19 patients beyond conventional biomarkers of disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/da4fcf94af0943caa330f6233a15e65c
work_keys_str_mv AT pierpaolopalumbo automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT mariamichelapalumbo automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT federicobruno automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT giovannapicchi automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT antonioiacopino automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT chiaraacanfora automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT ferrucciosgalambro automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT francescoarrigoni automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT arturociccullo automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT benedettacosimini automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT alessandrasplendiani automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT antoniobarile automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT francescomasedu automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT alessandrogrimaldi automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT ernestodicesare automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
AT carlomasciocchi automatedquantitativelungctimprovesprognosticationinnonicucovid19patientsbeyondconventionalbiomarkersofdisease
_version_ 1718412498880692224